Angiosarcoma follow up 2 validation study

ABSTRACT: A bespoke targeted pulldown experiment will be performed on patients with Angiosarcoma. the resulting products will be sequenced to determine the prevalence of previously found mutations in these patients.

PROVIDER: EGAS00001000518 | EGA |

REPOSITORIES: EGA